<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PLGE-RA-0779R2</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000606</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Dermatology/Psoriasis and Other Inflammatory Diseases</subject><subject>Genetics and Genomics/Complex Traits</subject><subject>Genetics and Genomics/Gene Discovery</subject><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Genetics and Genomics/Medical Genetics</subject></subj-group></article-categories><title-group><article-title>Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis</article-title><alt-title alt-title-type="running-head">Multiple Psoriasis Loci within the MHC</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Feng</surname><given-names>Bing-Jian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sun</surname><given-names>Liang-Dan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Soltani-Arabshahi</surname><given-names>Razieh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bowcock</surname><given-names>Anne M.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nair</surname><given-names>Rajan P.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stuart</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Elder</surname><given-names>James T.</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schrodi</surname><given-names>Steven J.</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Begovich</surname><given-names>Ann B.</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abecasis</surname><given-names>Gon&#x000e7;alo R.</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xue-Jun</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Callis-Duffin</surname><given-names>Kristina P.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Krueger</surname><given-names>Gerald G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Goldgar</surname><given-names>David E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Dermatology, University of Utah School of Medicine, Salt Lake City, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institute of Dermatology, Anhui Medical University, Hefei, China</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei, China</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Department of Dermatology, University of Michigan, Ann Arbor, Michigan, United States of America</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Celera, Alameda, California, United States of America</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Gojobori</surname><given-names>Takashi</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">National Institute of Genetics, Japan</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>david.goldgar@hsc.utah.edu</email></corresp><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Roche Diagnostics, Pleasanton, California, United States of America</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: BJF DEG. Performed the experiments: LDS. Analyzed the data: BJF. Contributed reagents/materials/analysis tools: BJF. Wrote the paper: BJF RSA AMB RPN PS JTE SJS ABB GRA XJZ KPCD GGK DEG.</p></fn></author-notes><pub-date pub-type="collection"><month>8</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>8</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>14</day><month>8</month><year>2009</year></pub-date><volume>5</volume><issue>8</issue><elocation-id>e1000606</elocation-id><history><date date-type="received"><day>11</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Feng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Psoriasis is a common inflammatory skin disease characterized by thickened scaly red plaques. Previously we have performed a genome-wide association study (GWAS) on psoriasis with 1,359 cases and 1,400 controls, which were genotyped for 447,249 SNPs. The most significant finding was for SNP rs12191877, which is in tight linkage disequilibrium with <italic>HLA-Cw&#x0002a;0602</italic>, the consensus risk allele for psoriasis. However, it is not known whether there are other psoriasis loci within the MHC in addition to <italic>HLA-C</italic>. In the present study, we searched for additional susceptibility loci within the human leukocyte antigen (HLA) region through in-depth analyses of the GWAS data; then, we followed up our findings in an independent Han Chinese 1,139 psoriasis cases and 1,132 controls. Using the phased CEPH dataset as a reference, we imputed the <italic>HLA-Cw&#x0002a;0602</italic> in all samples with high accuracy. The association of the imputed <italic>HLA-Cw&#x0002a;0602</italic> dosage with disease was much stronger than that of the most significantly associated SNP, rs12191877. Adjusting for <italic>HLA-Cw&#x0002a;0602</italic>, there were two remaining association signals: one demonstrated by rs2073048 (p&#x0200a;&#x0003d;&#x0200a;2&#x000d7;10<sup>&#x02212;6</sup>, OR&#x0200a;&#x0003d;&#x0200a;0.66), located within <italic>c6orf10</italic>, a potential downstream effecter of TNF-alpha, and one indicated by rs13437088 (p&#x0200a;&#x0003d;&#x0200a;9&#x000d7;10<sup>&#x02212;6</sup>, OR&#x0200a;&#x0003d;&#x0200a;1.3), located 30 kb centromeric of <italic>HLA-B</italic> and 16 kb telomeric of <italic>MICA</italic>. When <italic>HLA-Cw&#x0002a;0602</italic>, rs2073048, and rs13437088 were all included in a logistic regression model, each of them was significantly associated with disease (p&#x0200a;&#x0003d;&#x0200a;3&#x000d7;10<sup>&#x02212;47</sup>, 6&#x000d7;10<sup>&#x02212;8</sup>, and 3&#x000d7;10<sup>&#x02212;7</sup>, respectively). Both putative loci were also significantly associated in the Han Chinese samples after controlling for the imputed <italic>HLA-Cw&#x0002a;0602</italic>. A detailed analysis of <italic>HLA-B</italic> in both populations demonstrated that <italic>HLA-B&#x0002a;57</italic> was associated with an increased risk of psoriasis and <italic>HLA-B&#x0002a;40</italic> a decreased risk, independently of <italic>HLA-Cw&#x0002a;0602</italic> and the <italic>C6orf10</italic> locus, suggesting the potential pathogenic involvement of <italic>HLA-B</italic>. These results demonstrate that there are at least two additional loci within the MHC conferring risk of psoriasis.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Psoriasis (Ps) is a chronic inflammatory disease of the skin, affecting approximately 2&#x00025; of Europeans. The <italic>HLA-C</italic> gene, located within the major histocompatibility complex (MHC) region on chromosome 6, is the major genetic determinant of psoriasis. However, multiple susceptibility genes within MHC are also hypothesized. Recently, we carried out a genome-wide association scan (GWAS) on psoriasis with 1,359 patients and 1,400 healthy controls, which identified seven psoriasis loci in the human genome and confirmed the effect of <italic>HLA-C</italic>. This dataset contains densely distributed genetic variations, single nucleotide polymorphisms (SNPs), which were then further analyzed in search for additional susceptibility genes within the MHC region. Using the SNP data, we imputed in all samples the <italic>HLA-C</italic> risk allele with high accuracy. Adjusting for the <italic>HLA-C</italic>, two additional loci, one near <italic>C6orf10</italic> and one near <italic>HLA-B/MICA</italic>, have significant associations with psoriasis, which were also observed in an independent Han Chinese dataset, suggesting that within the MHC there are at least three genes moderating susceptibility to psoriasis.</p></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Psoriasis (Ps) is a relatively common, T cell-mediated, inflammatory skin disease. Ps is typically manifested as thickened scaly red plaques, characterized by epidermal hyperplasia, increased vascularity in the dermis, and infiltration of inflammatory cells into the dermis and epidermis <xref ref-type="bibr" rid="pgen.1000606-Lowes1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Griffiths1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Schon1">&#x0005b;3&#x0005d;</xref>. Both genetics and environment play a role in the etiology of Ps. Although its pathogenic mechanism is not completely understood, investigations have strongly suggested that a susceptibility locus (PSORS1) located within the human leukocyte antigen (HLA) class I region on the short arm of chromosome 6, is the major genetic determinant of psoriasis <xref ref-type="bibr" rid="pgen.1000606-Capon1">&#x0005b;4&#x0005d;</xref>. However, the exact location of the PSORS1 gene had been controversial, due to the extended and complicated linkage disequilibrium (LD) pattern of the region <xref ref-type="bibr" rid="pgen.1000606-Traherne1">&#x0005b;5&#x0005d;</xref>. Early studies had indicated the existence of two major PSORS1 locations suggested by various fine mapping studies, one a region &#x0223c;150 kb telomeric to <italic>HLA-C</italic><xref ref-type="bibr" rid="pgen.1000606-Orru1">&#x0005b;6&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-MartinezBorra1">&#x0005b;7&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Oka1">&#x0005b;8&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Lench1">&#x0005b;9&#x0005d;</xref>, harboring <italic>HCG27</italic>, <italic>POU5F1</italic>, <italic>TCF19</italic>, <italic>CCHCR1</italic> and <italic>CDSN</italic>, and the other <italic>HLA-C</italic> itself or very close <xref ref-type="bibr" rid="pgen.1000606-Balendran1">&#x0005b;10&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Nair1">&#x0005b;11&#x0005d;</xref>. Recently, a combined sequencing and haplotype mapping study found that within the 298 kb homologous region between the two proposed risk haplotypes, only <italic>HLA-C</italic> encoded variants unique to these haplotypes at the level of translated protein, which at the same time conferred increased risk of psoriasis, strongly suggesting that <italic>HLA-C</italic> is the Ps susceptibility gene, and excluded the telomeric region <xref ref-type="bibr" rid="pgen.1000606-Nair2">&#x0005b;12&#x0005d;</xref>. Similarly, two other family-based association studies, one in a white population and the other in a Chinese population, confirmed the direct involvement of <italic>HLA-C</italic> in psoriatic susceptibility <xref ref-type="bibr" rid="pgen.1000606-Fan1">&#x0005b;13&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Helms1">&#x0005b;14&#x0005d;</xref>. In terms of specific risk alleles, <italic>HLA-Cw&#x0002a;0602</italic> has been consistently reported in numerous populations, while the results have been controversial for <italic>HLA-Cw&#x0002a;1203</italic>, showing modest positive association with psoriasis in some studies <xref ref-type="bibr" rid="pgen.1000606-Helms1">&#x0005b;14&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Biral1">&#x0005b;15&#x0005d;</xref>, or no association <xref ref-type="bibr" rid="pgen.1000606-Nair2">&#x0005b;12&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Liao1">&#x0005b;16&#x0005d;</xref>, or even significantly lower frequency in psoriasis patents than in controls in others <xref ref-type="bibr" rid="pgen.1000606-Rani1">&#x0005b;17&#x0005d;</xref>.</p><p>Located 85 kb centromeric to <italic>HLA-C</italic>, <italic>HLA-B</italic> has also repeatedly exhibited association with psoriasis <xref ref-type="bibr" rid="pgen.1000606-Rahman1">&#x0005b;18&#x0005d;</xref>. However, the over-represented B serotypes, B&#x0002a;13 and B&#x0002a;57, are in tight LD with <italic>HLA-Cw&#x0002a;0602</italic><xref ref-type="bibr" rid="pgen.1000606-Dorak1">&#x0005b;19&#x0005d;</xref>; therefore, the association of <italic>HLA-B</italic> is thought to be attributable to <italic>HLA-C</italic>, or the <italic>HLA-Cw&#x0002a;0602</italic> harboring haplotypes 13.1 (Cw6-B13) and 57.1 (Cw6-B57), which are named according to the B allele <xref ref-type="bibr" rid="pgen.1000606-Jenisch1">&#x0005b;20&#x0005d;</xref>. Likewise, genes located farther from <italic>HLA-C</italic> at the centromeric end, including <italic>TNF-&#x003b1;</italic> (tumor necrosis factor-alpha) <xref ref-type="bibr" rid="pgen.1000606-Nedoszytko1">&#x0005b;21&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Li1">&#x0005b;22&#x0005d;</xref>, <italic>AGER</italic> (receptor of advanced glycosylation end product-specific receptor) <xref ref-type="bibr" rid="pgen.1000606-Vasku1">&#x0005b;23&#x0005d;</xref>, <italic>HLA-DRB1</italic>, <italic>HLA-DQA1</italic> and <italic>HLA-DQB1</italic><xref ref-type="bibr" rid="pgen.1000606-Zhang1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Jee1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Fatma1">&#x0005b;26&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Zhang2">&#x0005b;27&#x0005d;</xref>, have also been found to be associated with psoriasis. Although some of these genes are as far away from <italic>HLA-C</italic> as 1.38 megabases, the extended haplotype pattern of the HLA region still makes it probable that the association of these genes can be explained by LD with PSORS1, i.e. <italic>HLA-C</italic><xref ref-type="bibr" rid="pgen.1000606-Nair1">&#x0005b;11&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-SchmittEgenolf1">&#x0005b;28&#x0005d;</xref>.</p><p>Other findings have suggested the existence of another susceptibility gene in the major histocompatibility complex (MHC) in addition to <italic>HLA-C</italic>. A study found that the octamer transcription factor-3 (<italic>OTF3</italic>, also named <italic>POU5F1</italic>) B allele was more prevalent in patients than in controls, even within the <italic>HLA-Cw&#x0002a;0602</italic>-negative subset of samples <xref ref-type="bibr" rid="pgen.1000606-Gonzalez1">&#x0005b;29&#x0005d;</xref>. Moreover, less than 25 kb from this gene, two single nucleotide polymorphisms (SNPs) in the <italic>SEEK1</italic> (<italic>PSORS1C1</italic>) gene retained association with psoriasis upon stratification for <italic>HLA-Cw&#x0002a;0602</italic> status (positive/negative) <xref ref-type="bibr" rid="pgen.1000606-Holm1">&#x0005b;30&#x0005d;</xref>. However, these analyses did not consider <italic>HLA-Cw&#x0002a;1203</italic>, nor did they account for the increased risk associated with <italic>HLA-Cw&#x0002a;0602</italic> homozygotes <xref ref-type="bibr" rid="pgen.1000606-Gudjonsson1">&#x0005b;31&#x0005d;</xref>. Thus, analyses conditional on <italic>HLA-Cw&#x0002a;0602</italic> only, or upon stratification on <italic>HLA-Cw&#x0002a;0602</italic> positive/negative status, may not completely remove the confounding by <italic>HLA-C</italic>. Moreover, in contrast to the telomeric end, the centromeric end of <italic>HLA-C</italic> has rarely been investigated conditional on PSORS1.</p><p>Recently, within the framework of the Genetic Association Information Network (GAIN) we performed a multi-center collaborative genome-wide association study (GWAS), which identified seven Ps susceptibility loci at a genome-wide level of significance <xref ref-type="bibr" rid="pgen.1000606-Nair3">&#x0005b;32&#x0005d;</xref>. In this study, the most significantly associated SNP was rs12191877 (p&#x0200a;&#x0003d;&#x0200a;3&#x000d7;10<sup>&#x02212;53</sup>), which is in strong LD with <italic>HLA-Cw&#x0002a;0602</italic> (r<sup>2</sup>&#x0200a;&#x0003d;&#x0200a;0.63). In addition to this SNP, other MHC SNPs that reached genome-wide significance spanned a 4 Mb region, centering on <italic>HLA-C</italic>. Considering the widely scattered physical locations of these associated SNPs, the density of immune or inflammation related genes, and the above-mentioned multiple-susceptibility-genes in this region hypothesized to be associated with psoriasis, we searched for other psoriasis loci in the GAIN dataset by examining the MHC region in more detail. First, we used the CEPH phased data as a reference to derive a method of determining the <italic>HLA-C</italic> genotypes based on the SNPs genotyped as part of the GAIN projects <xref ref-type="bibr" rid="pgen.1000606-deBakker1">&#x0005b;33&#x0005d;</xref>. This was followed by a stepwise search for other susceptibility genes within the MHC region conditional on the predicted <italic>HLA-Cw&#x0002a;0602</italic>. The findings from these analyses were then replicated in an independent case-control dataset from a Chinese population. These results demonstrate that within the MHC region, there are at least two susceptibility loci for Ps in addition to <italic>HLA-C</italic>.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Imputation of <italic>HLA-Cw&#x0002a;0602</italic> and <italic>HLA-Cw&#x0002a;1203</italic> is accurate</title><p>Using the phased HLA and SNP genotypes contained in the HapMap CEU panel and additional CEPH samples <xref ref-type="bibr" rid="pgen.1000606-deBakker1">&#x0005b;33&#x0005d;</xref> as a reference set, we imputed in each GAIN subject the <italic>HLA-Cw&#x0002a;0602</italic> and <italic>HLA-Cw&#x0002a;1203</italic> genotypes, represented as the predicted number of <italic>HLA-Cw&#x0002a;0602</italic> or <italic>HLA-Cw&#x0002a;1203</italic> alleles. Since the SNP combinations used in the imputation were in complete linkage disequilibrium with the <italic>HLA-C</italic> allele of interest in the reference samples, the calculated uncertainties in the imputation only arose from haplotype reconstruction. In all GAIN samples, this uncertainty level was very low, indicated by the small average difference between the imputed and the most likely genotypes (0.002 and 0.0001 for <italic>HLA-Cw&#x0002a;0602</italic> and <italic>HLA-Cw&#x0002a;1203</italic>, respectively). In comparison with true <italic>HLA-C</italic> genotypes obtained from direct sequencing in a subset of our samples (n&#x0200a;&#x0003d;&#x0200a;420), there were no discrepancies observed for <italic>HLA-Cw&#x0002a;0602</italic>, and only 2 for <italic>HLA-Cw&#x0002a;1203</italic>, leading to a discordant rate of less than 0.5&#x00025; (<xref ref-type="table" rid="pgen-1000606-t001">Table 1</xref>).</p><table-wrap id="pgen-1000606-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000606.t001</object-id><label>Table 1</label><caption><title>Comparison of the imputed <italic>HLA-C</italic> genotypes with true genotypes.</title></caption><alternatives><graphic id="pgen-1000606-t001-1" xlink:href="pgen.1000606.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">HLA allele</td><td align="left" rowspan="1" colspan="1">Imputed number of alleles</td><td align="left" rowspan="1" colspan="1">&#x02212;/&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;/&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;/&#x0002b;</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Cw&#x0002a;0602</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">247</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.805</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.955</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.991</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.992</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.993</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.994</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.995</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.996</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.997</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.998</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.999</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">115</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.992</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.998</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Cw&#x0002a;1203</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">368</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.991</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.998</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.999</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="s2b"><title><italic>HLA-C</italic> is the major susceptibility gene within the MHC</title><p>In a logistic regression analysis, the imputed <italic>HLA-Cw&#x0002a;0602</italic> allele was clearly associated with psoriasis. Both the significance level and the magnitude of association were higher than those observed for the most significant genotyped SNP, rs12191877 (p&#x0200a;&#x0003d;&#x0200a;8&#x000d7;10<sup>&#x02212;61</sup> vs. p&#x0200a;&#x0003d;&#x0200a;3&#x000d7;10<sup>&#x02212;53</sup>; per allele OR&#x0200a;&#x0003d;&#x0200a;3.85 &#x0005b;3.25&#x02013;4.55&#x0005d; vs. OR&#x0200a;&#x0003d;&#x0200a;2.92 &#x0005b;2.54&#x02013;3.37&#x0005d;) (<xref ref-type="fig" rid="pgen-1000606-g001">Figure 1A</xref>). Another suggested risk allele of <italic>HLA-C</italic>, <italic>HLA-Cw&#x0002a;1203</italic> was significantly associated in logistic regression adjusted for <italic>HLA-Cw&#x0002a;0602</italic> (p&#x0200a;&#x0003d;&#x0200a;0.002, OR&#x0200a;&#x0003d;&#x0200a;1.44 &#x0005b;1.14&#x02013;1.81&#x0005d;), and in an analysis of the <italic>HLA-Cw&#x0002a;0602</italic>-negative subset of samples (p&#x0200a;&#x0003d;&#x0200a;0.004, OR&#x0200a;&#x0003d;&#x0200a;1.44 &#x0005b;1.12&#x02013;1.85&#x0005d;). Imputation of other <italic>HLA-C</italic> major alleles did not show any association with psoriasis (data not shown). These provide further confirmation that <italic>HLA-C</italic> is the major susceptibility gene at the PSORS1 locus, and that <italic>HLA-Cw&#x0002a;0602</italic> is the allele associated with the highest risk.</p><fig id="pgen-1000606-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000606.g001</object-id><label>Figure 1</label><caption><title>Association of MHC SNPs with psoriasis.</title><p>(A) Trend test of MHC SNPs in the GAIN dataset; (B) Logistic regression adjusted for <italic>HLA-Cw&#x0002a;0602</italic> in the GAIN dataset; (C) Logistic regression adjusted for <italic>HLA-Cw&#x0002a;0602</italic> and rs2073048 in the GAIN dataset. (D) Logistic regression adjusted for <italic>HLA-Cw&#x0002a;0602</italic> in the Chinese dataset; (E) Logistic regression adjusted for <italic>HLA-Cw&#x0002a;0602</italic> and rs28732201 in the Chinese dataset. The red lines indicate the significance level by Bonferroni correction for the number of SNPs tested. The numbers of SNPs are 1593, 1593, 1591, 226, and 252 for (A&#x02013;E), respectively.</p></caption><graphic xlink:href="pgen.1000606.g001"/></fig></sec><sec id="s2c"><title><italic>C6orf10</italic> is associated with psoriasis</title><p>To examine the association of other loci within the MHC region with psoriasis, we applied logistic regression analyses to all other genotyped SNPs in the MHC region (from 29.3 Mb to 33.7 Mb on chromosome 6) adjusting for the imputed <italic>HLA-Cw&#x0002a;0602</italic> genotype. As expected, given the patterns of linkage disequilibrium across this region, the levels of significance for association of the vast majority of SNPs dropped dramatically (<xref ref-type="fig" rid="pgen-1000606-g001">Figure 1B</xref>). The top SNP in the unadjusted analyses, rs12191877, was no longer even nominally significantly associated with Ps after adjustment for <italic>HLA-Cw&#x0002a;0602</italic>.</p><p>However, as seen in <xref ref-type="fig" rid="pgen-1000606-g001">Figure 1B</xref>, we observed other SNPs that remained significant after Bonferroni correction for multiple testing. The SNP exhibiting the highest significance level, rs2073048, is located at position 32.4 Mb within an open reading frame, <italic>C6orf10</italic>, 27 kb telomeric to <italic>BTNL2</italic> and 144 kb centromeric to <italic>NOTCH4</italic>. The minor allele (G) at this SNP had a frequency of 15&#x00025; in controls and was associated with an adjusted odds ratio of 0.66 (95&#x00025; confidence interval&#x0200a;&#x0003d;&#x0200a;&#x0005b;0.56&#x02013;0.78&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;2&#x000d7;10<sup>&#x02212;6</sup>). To better understand the relationship between this locus and <italic>HLA-C</italic>, we examined the effect of rs2073048 in a stratified analysis in which strata were defined by carriage of <italic>HLA-Cw&#x0002a;0602</italic>. The test of homogeneity of effect between strata showed no evidence of heterogeneity (p&#x0200a;&#x0003d;&#x0200a;0.78). In the subset of samples that does not contain an <italic>HLA-Cw&#x0002a;0602</italic> allele, rs2073048 was still significantly associated with psoriasis (OR&#x0200a;&#x0003d;&#x0200a;0.64 &#x0005b;0.53&#x02013;0.78&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;1&#x000d7;10<sup>&#x02212;5</sup>). These results suggest that the association of this locus with psoriasis is independent of <italic>HLA-Cw&#x0002a;0602</italic>.</p></sec><sec id="s2d"><title><italic>HLA-B/MICA</italic> is associated with psoriasis</title><p>Another cluster of SNPs exhibiting significant p-values after Bonferroni correction in <xref ref-type="fig" rid="pgen-1000606-g001">Figure 1B</xref> were between <italic>HLA-B</italic> and <italic>MICA</italic>. The most significant genotyped SNP of these, rs13437088, is located 30 kb centromeric of <italic>HLA-B</italic> and 16 kb telomeric of <italic>MICA</italic>. The minor allele of this SNP, T, had an allele frequency of 0.26 in controls, and was associated with an increased risk of psoriasis (OR&#x0200a;&#x0003d;&#x0200a;1.32 &#x0005b;1.17&#x02013;1.49&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;9&#x000d7;10<sup>&#x02212;6</sup>). In analyses adjusted for <italic>HLA-Cw&#x0002a;0602</italic> and rs2073048 (<xref ref-type="fig" rid="pgen-1000606-g001">Figure 1C</xref>), the association of this SNP was even stronger (OR&#x0200a;&#x0003d;&#x0200a;1.38 &#x0005b;1.22&#x02013;1.57&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;3&#x000d7;10<sup>&#x02212;7</sup>), suggesting that the observed association is not due to the LD with <italic>HLA-C</italic> or <italic>C6orf10</italic>.</p><p>In stratified analyses, there was no evidence of heterogeneity when samples were stratified by <italic>HLA-Cw&#x0002a;0602</italic>, rs2073048, or both (p&#x0200a;&#x0003d;&#x0200a;0.21, 0.26, and 0.58, respectively), showing that the association of this locus is independent of <italic>HLA-C</italic> and of the <italic>C6orf10</italic> locus. When both of the newly identified putative susceptibility loci and <italic>HLA-Cw&#x0002a;0602</italic> were included in a logistic regression model, each of them was significantly associated with disease (p&#x0200a;&#x0003d;&#x0200a;3&#x000d7;10<sup>&#x02212;47</sup>, 6&#x000d7;10<sup>&#x02212;8</sup> and 3&#x000d7;10<sup>&#x02212;7</sup>, for <italic>HLA-Cw&#x0002a;0602</italic>, rs2073048 and rs13437088, respectively). Individuals carrying risk genotypes at <italic>HLA-C</italic>, rs2073048 and rs13437088 were estimated to be at a nine-fold increased risk of psoriasis compared to those carrying low risk genotypes at all three loci (<xref ref-type="table" rid="pgen-1000606-t002">Table 2</xref>).</p><table-wrap id="pgen-1000606-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000606.t002</object-id><label>Table 2</label><caption><title>Psoriasis risk conferred by the three MHC loci in the GAIN dataset.</title></caption><alternatives><graphic id="pgen-1000606-t002-2" xlink:href="pgen.1000606.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Cw&#x0002a;0602</td><td align="left" rowspan="1" colspan="1">rs13437088<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">rs2073048<xref ref-type="table-fn" rid="nt102">b</xref></td><td align="left" rowspan="1" colspan="1">Case (&#x00025;)</td><td align="left" rowspan="1" colspan="1">Control (&#x00025;)</td><td align="left" rowspan="1" colspan="1">O.R. &#x0005b;95&#x00025;CI&#x0005d;</td><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">54 (4)</td><td align="left" rowspan="1" colspan="1">146 (10)</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Ref.</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">306 (23)</td><td align="left" rowspan="1" colspan="1">518 (37)</td><td align="left" rowspan="1" colspan="1">1.60 &#x0005b;1.13&#x02013;2.25&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">86 (6)</td><td align="left" rowspan="1" colspan="1">189 (14)</td><td align="left" rowspan="1" colspan="1">1.23 &#x0005b;0.82&#x02013;1.84&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">277 (20)</td><td align="left" rowspan="1" colspan="1">308 (22)</td><td align="left" rowspan="1" colspan="1">2.43 &#x0005b;1.71&#x02013;3.46&#x0005d;</td><td align="left" rowspan="1" colspan="1">5&#x000d7;10<sup>&#x02212;7</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">25 (2)</td><td align="left" rowspan="1" colspan="1">19 (1)</td><td align="left" rowspan="1" colspan="1">3.56 &#x0005b;1.81&#x02013;6.97&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">192 (14)</td><td align="left" rowspan="1" colspan="1">86 (6)</td><td align="left" rowspan="1" colspan="1">6.04 &#x0005b;4.04&#x02013;9.03&#x0005d;</td><td align="left" rowspan="1" colspan="1">1&#x000d7;10<sup>&#x02212;19</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">75 (6)</td><td align="left" rowspan="1" colspan="1">28 (2)</td><td align="left" rowspan="1" colspan="1">7.24 &#x0005b;4.24&#x02013;12.4&#x0005d;</td><td align="left" rowspan="1" colspan="1">2&#x000d7;10<sup>&#x02212;14</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td><td align="left" rowspan="1" colspan="1">342 (25)</td><td align="left" rowspan="1" colspan="1">104 (7)</td><td align="left" rowspan="1" colspan="1">8.89 &#x0005b;6.07&#x02013;13.0&#x0005d;</td><td align="left" rowspan="1" colspan="1">5&#x000d7;10<sup>&#x02212;33</sup></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>&#x02018;&#x0002b;&#x02019; denotes genotype CT/TT (presence of the risk allele T);</p></fn><fn id="nt102"><label>b</label><p>&#x02018;&#x0002b;&#x02019; denotes genotype AA (absence of the protective allele G).</p></fn></table-wrap-foot></table-wrap><p>To assess whether <italic>HLA-B</italic> is responsible for the association of rs13437088 with psoriasis risk, we imputed all <italic>HLA-B</italic> serotypes with CEPH population frequencies &#x0003e;5&#x00025;, as well as those serotypes previously suggested to be associated with psoriasis (B&#x0002a;13, B&#x0002a;57 and B&#x0002a;58). In a logistic regression analysis adjusted for <italic>HLA-Cw&#x0002a;0602</italic> and rs2073048, two B serotypes (B&#x0002a;40 and B&#x0002a;57) were significantly associated with psoriasis after Bonferroni correction for testing multiple serotypes: One additional copy of B&#x0002a;57 conferred a 1.7 fold elevated risk of disease, while B&#x0002a;40 was associated with a 40&#x00025; reduced risk. In individuals who did not carry <italic>HLA-Cw&#x0002a;0602</italic>, B&#x0002a;40 remained significantly associated, while B&#x0002a;57 did not (<xref ref-type="table" rid="pgen-1000606-t003">Table 3</xref>). This can be explained by the fact that B&#x0002a;57 is in tight LD with <italic>HLA-Cw&#x0002a;0602</italic>, while B&#x0002a;40 is not in LD with <italic>HLA-Cw&#x0002a;0602</italic><xref ref-type="bibr" rid="pgen.1000606-Dorak1">&#x0005b;19&#x0005d;</xref>. The SNP rs13437088 was in high LD with B&#x0002a;57 (D'&#x0200a;&#x0003d;&#x0200a;1).</p><table-wrap id="pgen-1000606-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000606.t003</object-id><label>Table 3</label><caption><title>Association of major <italic>HLA-B</italic> serotypes with psoriasis in the GAIN dataset.</title></caption><alternatives><graphic id="pgen-1000606-t003-3" xlink:href="pgen.1000606.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">HLA-B serotype</td><td align="left" rowspan="1" colspan="1">Adjusted O.R. &#x0005b;95&#x00025;CI&#x0005d;<xref ref-type="table-fn" rid="nt103">a</xref></td><td align="left" rowspan="1" colspan="1">Adjusted p-value<xref ref-type="table-fn" rid="nt103">a</xref></td><td align="left" rowspan="1" colspan="1">Cw6 -/- O.R. &#x0005b;95&#x00025;CI&#x0005d;<xref ref-type="table-fn" rid="nt104">b</xref></td><td align="left" rowspan="1" colspan="1">Cw6 -/- p-value<xref ref-type="table-fn" rid="nt104">b</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">0.90 &#x0005b;0.75&#x02013;1.07&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">0.91 &#x0005b;0.74&#x02013;1.10&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">1.13 &#x0005b;0.93&#x02013;1.37&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.23</td><td align="left" rowspan="1" colspan="1">1.13 &#x0005b;0.91&#x02013;1.38&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">1.16 &#x0005b;0.83&#x02013;1.64&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1">1.26 &#x0005b;0.47&#x02013;3.37&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">1.01 &#x0005b;0.81&#x02013;1.26&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">1.09 &#x0005b;0.86&#x02013;1.39&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">0.96 &#x0005b;0.71&#x02013;1.30&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">0.93 &#x0005b;0.68&#x02013;1.29&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">0.91 &#x0005b;0.74&#x02013;1.13&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">0.90 &#x0005b;0.71&#x02013;1.14&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.38</td></tr><tr><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">0.61 &#x0005b;0.47&#x02013;0.79&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.0002<xref ref-type="table-fn" rid="nt105">c</xref></td><td align="left" rowspan="1" colspan="1">0.65 &#x0005b;0.49&#x02013;0.87&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.003<xref ref-type="table-fn" rid="nt105">c</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">0.85 &#x0005b;0.71&#x02013;1.03&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.77 &#x0005b;0.62&#x02013;0.95&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">1.66 &#x0005b;1.25&#x02013;2.19&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.0004<xref ref-type="table-fn" rid="nt105">c</xref></td><td align="left" rowspan="1" colspan="1">2.92 &#x0005b;1.36&#x02013;6.25&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">1.22 &#x0005b;0.54&#x02013;2.73&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">1.09 &#x0005b;0.44&#x02013;2.71&#x0005d;</td><td align="left" rowspan="1" colspan="1">0.85</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label>a</label><p>Adjusted for <italic>HLA-Cw&#x0002a;0602</italic> and rs2073048;</p></fn><fn id="nt104"><label>b</label><p>In the <italic>HLA-Cw&#x0002a;0602</italic>-negative subset of samples, adjusted for rs2073048;</p></fn><fn id="nt105"><label>c</label><p>Significant after Bonferroni correction (p&#x0003c;0.005).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2e"><title>Replication of both loci in a Han Chinese population</title><p>To further confirm our findings of the two novel loci for psoriasis within MHC, we tested them in an independent Han Chinese sample that was included in another GWAS of psoriasis <xref ref-type="bibr" rid="pgen.1000606-Zhang3">&#x0005b;34&#x0005d;</xref>. Using the Han Chinese and Japanese HapMap data as a reference, <italic>HLA-Cw&#x0002a;0602</italic> genotypes were imputed using strategies identical to those for the US sample. The predicted <italic>HLA-Cw&#x0002a;0602</italic> allele was strongly associated with psoriasis (p&#x0200a;&#x0003d;&#x0200a;1&#x000d7;10<sup>&#x02212;206</sup>), which is quite comparable to the top SNP rs1265181 (p&#x0200a;&#x0003d;&#x0200a;2&#x000d7;10<sup>&#x02212;208</sup>) <xref ref-type="bibr" rid="pgen.1000606-Zhang3">&#x0005b;34&#x0005d;</xref>, whose genotypes were 99.6&#x00025; identical to the predicted <italic>HLA-Cw&#x0002a;0602</italic>, showing that <italic>HLA-Cw&#x0002a;0602</italic> is the main susceptibility allele within the PSORS1 region. On the other hand, <italic>HLA-Cw&#x0002a;1203</italic> was not associated with psoriasis in this population, after adjustment for <italic>HLA-Cw&#x0002a;0602</italic> or within the <italic>HLA-Cw&#x0002a;0602</italic>-negative subset of samples.</p><p>To assess the two loci we observed in the US samples, we first tested all genotyped SNPs within 100 kb of rs2073048, the first locus we identified in the US study. The results indicated several SNPs that were significantly associated, the most significant of which was the SNP rs28732201, which had a minor allele frequency of 0.01, and odds ratio of 2.85 &#x0005b;1.81&#x02013;4.50&#x0005d; with a p-value of 7&#x000d7;10<sup>&#x02212;6</sup> (<xref ref-type="fig" rid="pgen-1000606-g001">Figure 1D</xref>). This SNP is located between <italic>C6orf10</italic> and <italic>BTNL2</italic>, 11 kb upstream to the transcription start site of <italic>C6orf10</italic>, and 12 kb downstream to the transcription end site of <italic>BTNL2</italic>. After adjustment for both <italic>HLA-Cw&#x0002a;0602</italic> and rs28732201, the locus of <italic>HLA-B/MICA</italic> (within 100 kb of the SNP identified in the GAIN dataset) also exhibited significant association, shown by the SNP rs2442719 (OR&#x0200a;&#x0003d;&#x0200a;1.66 &#x0005b;1.36&#x02013;2.03&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;8&#x000d7;10<sup>&#x02212;7</sup>, <xref ref-type="fig" rid="pgen-1000606-g001">Figure 1E</xref>), located only 1 kb from the telomeric end of <italic>HLA-B</italic>. When <italic>HLA-Cw&#x0002a;0602</italic>, rs28732201 and rs2442719 were all included in a logistic regression model, they all remained significantly associated (p&#x0200a;&#x0003d;&#x0200a;2&#x000d7;10<sup>&#x02212;102</sup>, 1&#x000d7;10<sup>&#x02212;5</sup>, and 8&#x000d7;10<sup>&#x02212;7</sup>, respectively).</p><p>We also imputed the B&#x0002a;40 and B&#x0002a;57 serotypes in these Chinese samples and tested their associations with psoriasis controlling for <italic>HLA-Cw&#x0002a;0602</italic>. Interestingly, similar to the US data, B&#x0002a;57 was significantly associated with an increased risk of psoriasis (OR&#x0200a;&#x0003d;&#x0200a;2.71 &#x0005b;1.81&#x02013;4.06&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;1&#x000d7;10<sup>&#x02212;6</sup>), and B&#x0002a;40 with a reduced risk (OR&#x0200a;&#x0003d;&#x0200a;0.74 &#x0005b;0.57&#x02013;0.97&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;0.03). These associations remained nominally significant when analyses were further adjusted for the <italic>C6orf10</italic> locus (OR&#x0200a;&#x0003d;&#x0200a;0.75 &#x0005b;0.58&#x02013;0.98&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;0.04 for B&#x0002a;40 and OR&#x0200a;&#x0003d;&#x0200a;1.98 &#x0005b;1.05&#x02013;3.73&#x0005d;, p&#x0200a;&#x0003d;&#x0200a;0.03 for B&#x0002a;57).</p></sec></sec><sec id="s3"><title>Discussion</title><p>The association of <italic>HLA-C</italic> with psoriasis was first proposed as early as 30 years ago <xref ref-type="bibr" rid="pgen.1000606-McMichael1">&#x0005b;35&#x0005d;</xref>. However, until recently doubts remained as to whether <italic>HLA-C</italic> or a nearby gene was the locus responsible for the observed association. One of the difficulties contributing to this is the fact that the HLA region has a complicated and extended linkage disequilibrium pattern, while harboring many immune response genes in high density. Recently, sequencing and haplotype analyses studies have concluded that <italic>HLA-C</italic> is the major risk determinant of psoriasis within the HLA region, and <italic>HLA-Cw&#x0002a;0602</italic> is the main risk allele. However, one immediate question arose: is <italic>HLA-C</italic> the only susceptibility gene in this region? This question turns out to be challenging because any other putative psoriasis predisposing genes would have a weaker effect than <italic>HLA-Cw&#x0002a;0602</italic>, and the analyses would be complicated by potential linkage disequilibrium with <italic>HLA-C</italic>. To control for the effects of <italic>HLA-C</italic>, it would be optimal to use the <italic>HLA-C</italic> genotype <italic>per se</italic>; however, in a large multi-center study such as the present one, molecular typing of the HLA alleles would not be readily available. In this paper, we used the CEPH phased data which contains the phased alleles at <italic>HLA-A, -B, -C &#x02013;DR</italic> and <italic>&#x02013;DQ</italic> as well as thousands of SNPs in this region as a reference sample to identify SNPs that can accurately predict the <italic>HLA-C</italic> alleles. These genotypes can then be used to perform analyses to search for other susceptibility genes. As our validation study illustrated, we were able to accurately predict the <italic>HLA-C</italic> alleles in the GAIN samples, in spite of it being composed of a diverse (though all white) mixture of individuals of differing European backgrounds. In addition to the present study, others have found similar utility of this approach across European-derived populations. For example, a validation assessment of the imputation method carried out on Dutch, UK, Spanish, and Italian samples showed high sensitivity and specificity in imputing <italic>DQA1</italic>, <italic>DQB1</italic> and <italic>DRB1</italic> alleles <xref ref-type="bibr" rid="pgen.1000606-deBakker1">&#x0005b;33&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Monsuur1">&#x0005b;36&#x0005d;</xref>. Moreover, the genomic control <xref ref-type="bibr" rid="pgen.1000606-Devlin1">&#x0005b;37&#x0005d;</xref> parameter of our samples was 1.03, suggesting that population stratification has negligible impact on our association results <xref ref-type="bibr" rid="pgen.1000606-Nair3">&#x0005b;32&#x0005d;</xref>.</p><p>Through this imputation, we confirmed that <italic>HLA-Cw&#x0002a;0602</italic> is the major psoriasis risk determinant within the HLA region, which has a much stronger association with psoriasis than the most significantly associated SNP, rs12191877. This has reinforced the importance of using <italic>HLA-C</italic> risk allele <italic>per se</italic> in the analyses of MHC, since adjusting for the surrogate SNP cannot fully control for <italic>HLA-C</italic>. Our analyses also provided further evidence that <italic>HLA-Cw&#x0002a;1203</italic> is associated with psoriasis, although it is not clear whether <italic>HLA-Cw&#x0002a;1203</italic> is a risk allele itself, or is in LD with the risk allele of another susceptibility gene near <italic>HLA-C</italic>. On the other hand, <italic>HLA-Cw&#x0002a;1203</italic> was not associated with psoriasis in the Han Chinese after adjustment for <italic>HLA-Cw&#x0002a;0602</italic>. These may imply that <italic>HLA-Cw&#x0002a;1203</italic> does not confer risk to psoriasis; the discrepancies in its association with psoriasis in different studies may be due to the different LD patterns among populations.</p><p>To search for additional loci for psoriasis in the MHC region, we conducted logistic regression analyses adjusting for the imputed <italic>HLA-Cw&#x0002a;0602</italic>, and identified two loci within 1.2 Mb of <italic>HLA-C</italic>, one around the <italic>C6orf10</italic> gene, and one between <italic>HLA-B</italic> and <italic>MICA</italic>. Both of these loci were significantly associated with disease risk after Bonferroni correction for the number of SNPs considered in the analyses. Furthermore, data analyses demonstrate that they are not simply reflecting linkage disequilibrium with <italic>HLA-C</italic>, since 1) the associations are not secondary to <italic>HLA-Cw&#x0002a;0602</italic> as shown in the analyses adjusted for <italic>HLA-Cw&#x0002a;0602</italic> or within the <italic>HLA-Cw&#x0002a;0602</italic>-negative subset of samples, 2) further adjustment for <italic>HLA-Cw&#x0002a;1203</italic> in analyses did not substantially change our results, and 3) no other <italic>HLA-C</italic> major allele showed association with psoriasis in our data. More importantly, both associated loci were replicated in an independent Han Chinese dataset after adjustment for <italic>HLA-Cw&#x0002a;0602</italic>, even though the LD patterns in Chinese are quite different from those in the GAIN dataset. All these observations imply the existence of other psoriasis risk-determining genes within the MHC. When the putative susceptibility loci and <italic>HLA-Cw&#x0002a;0602</italic> were included in a logistic regression model, they all remained significantly associated with disease, showing that these loci are not attributable to each other; therefore, within the MHC there are at least three genes conferring risk of psoriasis.</p><p>The first locus we identified is located 1.1 Mb centromeric of <italic>HLA-C</italic>, indicated by the SNP rs2073048. It is noteworthy that in our previous paper, using a forward selection technique, we also found some evidence of another SNP (rs2022544) close to this locus that was associated with Ps, but this study did not control for the <italic>HLA-C</italic> risk allele, but rather for its surrogate SNP <xref ref-type="bibr" rid="pgen.1000606-Nair3">&#x0005b;32&#x0005d;</xref>, rendering the results subject to residual association of <italic>HLA-C</italic>. The SNP rs2073048 is located within the 4<sup>th</sup> intron of an open reading frame <italic>C6orf10</italic>, 27 kb telemetric to <italic>BTNL2</italic> and 144 kb centromeric to <italic>NOTCH4</italic>. There have been previous reports of association of psoriasis with <italic>AGER</italic>, which is 183 kb telomeric of rs2073048, and with <italic>HLA-DRB1</italic> that is 211 kb centromeric of rs2073048. In the present study, analyses of imputed serotypes of <italic>HLA-DRB1</italic> did not support the involvement of <italic>HLA-DRB1</italic> in disease pathogenesis (data not shown). Furthermore, as noted before, there is a recombination hot spot centromeric to <italic>NOTCH4</italic><xref ref-type="bibr" rid="pgen.1000606-Miretti1">&#x0005b;38&#x0005d;</xref>, reducing the possibility that the association at this locus is attributable to those genes located telomeric to the recombination hot spot (<italic>NOTCH4</italic>, <italic>AGER</italic>, etc.), although they still cannot be completely excluded. Thus, <italic>C6orf10</italic> and <italic>BTNL2</italic> are better candidate genes for this locus. The most associated SNP found in the GAIN dataset (rs2073048) after correction for <italic>HLA-Cw&#x0002a;0602</italic> is located within <italic>C6orf10</italic>, and the SNP found in the Chinese dataset (rs28732201) is close to the transcription start site of <italic>C6orf10</italic>; therefore, <italic>C6orf10</italic> is one of the most important candidate genes at this locus. It has been observed that the transcription of <italic>C6orf10</italic> in keratinocytes can be triggered by TNF-&#x003b1; (Gene Expression Omnibus dataset number: GDS1289) <xref ref-type="bibr" rid="pgen.1000606-Banno1">&#x0005b;39&#x0005d;</xref>, an important proinflammatory cytokine in the pathogenesis of psoriasis, although the function of the <italic>C6orf10</italic> product is not known. Nevertheless, other genes cannot be excluded; more haplotype and sequencing analyses will be required to pinpoint the risk-conferring variants at this locus.</p><p>The second locus we observed after adjustment for <italic>HLA-C</italic> and <italic>C6orf10</italic> is between <italic>HLA-B</italic> and <italic>MICA</italic>, located 117 kb centromeric to <italic>HLA-C</italic>, suggesting the potential association of <italic>HLA-B</italic> or <italic>MICA</italic> with psoriasis risk. In the Chinese samples, this locus was also indicated by logistic regression analyses adjusted for <italic>HLA-C</italic> and <italic>C6orf10</italic>, by a SNP located only 1 kb telomeric to <italic>HLA-B</italic>. More importantly, although the linkage disequilibrium patterns and the <italic>HLA-B</italic> tagging SNPs were different between Chinese and white populations, the same <italic>HLA-B</italic> serotypes were associated with psoriasis: B&#x0002a;57 with an increased risk and B&#x0002a;40 with a reduced risk. These are suggestive of the involvement of <italic>HLA-B</italic> in psoriasis etiology. The role of <italic>HLA-B</italic> in psoriasis immuno-pathogenesis might be similar to that of <italic>HLA-C</italic>, which has been shown to bind peptide motifs that are shared between the streptococcal M proteins and the wound-healing-associated keratins k16 and k17, thereby clonally expanding the pool of skin-directed autoreactive CD8&#x0002b; T cells <xref ref-type="bibr" rid="pgen.1000606-Johnston1">&#x0005b;40&#x0005d;</xref>. Another candidate gene for this locus, <italic>MICA</italic>, is a distant homolog of the MHC class I protein. It can be induced by cellular or metabolic stress in the epithelia, acting as ligands for the activatory T-cell receptor, NKG2D. In psoriasis, it has been shown that MICA is down-regulated in lesional skin compared with non-lesional skin (p&#x0200a;&#x0003d;&#x0200a;0.007, Gene Expression Omnibus dataset number: GDS2518) <xref ref-type="bibr" rid="pgen.1000606-Reischl1">&#x0005b;41&#x0005d;</xref>. The under-expression of the MICA protein might allow the unwanted cells to escape the cytolysis by NK or CD8&#x0002b; T-cells, resulting in keratinocyte proliferation and the enhanced inflammation inherent to lesions of psoriasis. Other genes within this region still cannot be excluded by our analyses; more detailed studies of <italic>HLA-B</italic> serotypes and MHC haplotypes are required to further elucidate the association of this locus with psoriasis.</p><p>The study of associations in the MHC region is notoriously difficult due to the presence of many genes involved in immune and inflammatory processes as well as the extensive and complex patterns of linkage disequilibrium. Our use of a genome-wide panel of SNPs that included nearly 2000 SNPs within the MHC, a validated prediction method to determine with high probability the presence of known <italic>HLA-C</italic> risk alleles for Ps, and a large sample of psoriasis cases and controls allowed us to begin to tease out different effects on psoriasis risk within the MHC region. Our discoveries are replicated in independent samples from another race, reinforcing the evidence of our findings. In combination with the loci reported in our previous work <xref ref-type="bibr" rid="pgen.1000606-Nair3">&#x0005b;32&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Cargill1">&#x0005b;42&#x0005d;</xref>, and those yet to be identified from large-scale replication studies of thousands of loci arising from our own and other genome-wide association studies, we anticipate that substantial progress will be made in the coming months in explaining the genetic basis of psoriasis. Perhaps more relevantly, we anticipate that some of the genes identified will prove to be attractive therapeutic targets, leading to improved treatment for this disease.</p><p>In conclusion, we provide evidence that two loci within the HLA region in addition to <italic>HLA-C</italic>, one near <italic>C6orf10</italic> and one near <italic>HLA-B</italic>, are significantly associated with psoriasis, suggesting that within MHC there are at least three genes moderating susceptibility to psoriasis. However we fully recognize that additional studies including re-sequencing and detailed haplotype analysis will be required to elucidate the causal variants.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Subject recruitment</title><p>The initial genome wide association scan involved 1409 psoriasis patients and 1436 controls recruited from the University of Utah, the University of Michigan, and the Washington University at St. Louis, USA. All cases and controls were of European descent. Informed consent was obtained from each participant. In total, 1359 cases and 1400 controls with 447,249 SNP genotypes passed the quality control process. The average age at onset of psoriasis was 24.3 years with the majority of patients (1127, 82.9&#x00025;) developing psoriasis before age 40. Additional details on subject characteristics and recruitment can be found in Nair et al <xref ref-type="bibr" rid="pgen.1000606-Nair3">&#x0005b;32&#x0005d;</xref>.</p><p>The samples in the replication analyses were 1139 cases and 1132 controls used in the initial GWAS of psoriasis conducted at the Anhui Medical University, Hefei city, Anhui province, China. These samples were recruited from Han Chinese populations by multiple hospitals in China. More details about the studied samples are described elsewhere <xref ref-type="bibr" rid="pgen.1000606-Zhang3">&#x0005b;34&#x0005d;</xref>. The local institutional review board at each site approved the study protocol.</p></sec><sec id="s4b"><title><italic>HLA-C</italic>, <italic>HLA-B</italic>, and <italic>HLA-DRB1</italic> genotype imputation</title><p>We used the phased HLA and SNP genotypes contained in the HapMap CEU panel (30 trios) and an additional set of 90 CEPH samples <xref ref-type="bibr" rid="pgen.1000606-deBakker1">&#x0005b;33&#x0005d;</xref> to search for SNP combinations in linkage disequilibrium with specific HLA alleles, using an approach similar to that taken by de Bakker et al <xref ref-type="bibr" rid="pgen.1000606-deBakker1">&#x0005b;33&#x0005d;</xref>, except that whenever possible, a combination of 3 to 4 SNPs was used. In each of our GAIN samples, we inferred the haplotypes of these chosen SNPs and the corresponding haplotype probabilities using the PHASE program version 2.1 <xref ref-type="bibr" rid="pgen.1000606-Stephens1">&#x0005b;43&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000606-Stephens2">&#x0005b;44&#x0005d;</xref>, for case and control populations separately as suggested by Mensah et al <xref ref-type="bibr" rid="pgen.1000606-Mensah1">&#x0005b;45&#x0005d;</xref>. The imputed HLA genotype containing an allele of interest was represented as the estimated number of copies of each specific allele, and was calculated by summing the probability of having that allele given a specific haplotype, weighted by the corresponding haplotype probability:<disp-formula><graphic xlink:href="pgen.1000606.e001"/></disp-formula>where <italic>g</italic> is the imputed number of HLA alleles, <italic>A<sub>i&#x02022;</sub></italic> denotes an event that the haplotype <italic>i&#x02022;</italic> contains the HLA allele of interest, <italic>h<sub>i&#x02022;</sub></italic> is one of the two haplotypes of the haplotype assignment <italic>i</italic> from PHASE, and <italic>p(h<sub>i</sub>)</italic> is the haplotype probability. The <italic>p(A<sub>i&#x02022;</sub>|h<sub>i</sub>)</italic> was directly obtained from the reference samples, and the <italic>p(h<sub>i</sub>)</italic> was calculated by the PHASE program. Thus, the uncertainties from the incomplete LD between the haplotype and the HLA allele, and from the haplotype reconstruction, were both integrated into the imputation; although not all uncertainty can be estimated due to the relatively small size of the HapMap and CEPH sample. To gain more power in association test, we minimized the overall uncertainty level (estimated by the averaged difference between the imputed and the most likely genotype), by maximizing the LD between the haplotype and the HLA allele, and by maximizing the haplotype probabilities by inclusion of nearby SNPs in low LD with the HLA imputing SNPs in haplotype reconstruction. These additional SNPs were selected by the HAPLOVIEW program <xref ref-type="bibr" rid="pgen.1000606-Barrett1">&#x0005b;46&#x0005d;</xref>, with a threshold of r<sup>2</sup>&#x0003c;0.1. For better imputation accuracies, a more stringent quality control strategy than the GWAS was applied, where those SNPs with &#x0003c;99.5&#x00025; genotype call rates, or with evidence for departure from Hardy-Weinberg equilibrium at p&#x0003c;0.001 among controls, were not considered. To validate the imputed <italic>HLA-C</italic> genotypes, a sub-sample of 420 Utah psoriasis patients were genotyped using direct sequencing at Atria Inc. (South San Francisco, CA).</p></sec><sec id="s4c"><title>Association analyses</title><p>e conducted trend tests to assess the association between SNPs and psoriasis, using the PLINK program <xref ref-type="bibr" rid="pgen.1000606-Purcell1">&#x0005b;47&#x0005d;</xref>. To examine the association of a specific HLA allele with psoriasis, we used logistic regression analysis on the imputed HLA genotype, weighted according to genotype probabilities as suggested by Mensah et al <xref ref-type="bibr" rid="pgen.1000606-Mensah1">&#x0005b;45&#x0005d;</xref>, i.e., in our analyses of HLA, we used the imputed number of alleles (real number between 0 and 2), rather than the most likely number of alleles (0, 1 or 2) in logistic regression. To examine other SNPs within the HLA region, logistic regression was performed adjusted for <italic>HLA-C</italic> and associated SNP genotype, using the PLINK program <xref ref-type="bibr" rid="pgen.1000606-Purcell1">&#x0005b;47&#x0005d;</xref>. Averaged odds ratio and the corresponding 95&#x00025; confidence intervals for each additional number of minor allele of the studied SNP were calculated. Linkage disequilibrium plots and recombination rate plots were produced using the HapMap phase II data <xref ref-type="bibr" rid="pgen.1000606-Frazer1">&#x0005b;48&#x0005d;</xref> by a C&#x0002b;&#x0002b; program written by the authors.</p></sec></sec></body><back><ref-list><title>References</title><ref id="pgen.1000606-Lowes1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowes</surname><given-names>MA</given-names></name><name><surname>Bowcock</surname><given-names>AM</given-names></name><name><surname>Krueger</surname><given-names>JG</given-names></name></person-group><year>2007</year><article-title>Pathogenesis and therapy of psoriasis.</article-title><source>Nature</source><volume>445</volume><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">17314973</pub-id></mixed-citation></ref><ref id="pgen.1000606-Griffiths1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>CE</given-names></name><name><surname>Barker</surname><given-names>JN</given-names></name></person-group><year>2007</year><article-title>Pathogenesis and clinical features of psoriasis.</article-title><source>Lancet</source><volume>370</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">17658397</pub-id></mixed-citation></ref><ref id="pgen.1000606-Schon1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>MP</given-names></name><name><surname>Boehncke</surname><given-names>WH</given-names></name></person-group><year>2005</year><article-title>Psoriasis.</article-title><source>N Engl J Med</source><volume>352</volume><fpage>1899</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">15872205</pub-id></mixed-citation></ref><ref id="pgen.1000606-Capon1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capon</surname><given-names>F</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name><name><surname>Barker</surname><given-names>JN</given-names></name></person-group><year>2004</year><article-title>An update on the genetics of psoriasis.</article-title><source>Dermatol Clin</source><volume>22</volume><fpage>339</fpage><lpage>347, vii</lpage><pub-id pub-id-type="pmid">15450331</pub-id></mixed-citation></ref><ref id="pgen.1000606-Traherne1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traherne</surname><given-names>JA</given-names></name></person-group><year>2008</year><article-title>Human MHC architecture and evolution: implications for disease association studies.</article-title><source>Int J Immunogenet</source><volume>35</volume><fpage>179</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">18397301</pub-id></mixed-citation></ref><ref id="pgen.1000606-Orru1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orru</surname><given-names>S</given-names></name><name><surname>Giuressi</surname><given-names>E</given-names></name><name><surname>Carcassi</surname><given-names>C</given-names></name><name><surname>Casula</surname><given-names>M</given-names></name><name><surname>Contu</surname><given-names>L</given-names></name></person-group><year>2005</year><article-title>Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN).</article-title><source>Am J Hum Genet</source><volume>76</volume><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">15529278</pub-id></mixed-citation></ref><ref id="pgen.1000606-MartinezBorra1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Borra</surname><given-names>J</given-names></name><name><surname>Brautbar</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Enk</surname><given-names>CD</given-names></name><name><surname>Lopez-Vazquez</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>The region of 150 kb telometic to HLA-C is associated with psoriasis in the Jewish population.</article-title><source>J Invest Dermatol</source><volume>125</volume><fpage>928</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">16297191</pub-id></mixed-citation></ref><ref id="pgen.1000606-Oka1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname><given-names>A</given-names></name><name><surname>Tamiya</surname><given-names>G</given-names></name><name><surname>Tomizawa</surname><given-names>M</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Katsuyama</surname><given-names>Y</given-names></name><etal/></person-group><year>1999</year><article-title>Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene.</article-title><source>Hum Mol Genet</source><volume>8</volume><fpage>2165</fpage><lpage>2170</lpage><pub-id pub-id-type="pmid">10545595</pub-id></mixed-citation></ref><ref id="pgen.1000606-Lench1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lench</surname><given-names>N</given-names></name><name><surname>Iles</surname><given-names>MM</given-names></name><name><surname>Mackay</surname><given-names>I</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Sagoo</surname><given-names>GS</given-names></name><etal/></person-group><year>2005</year><article-title>Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatability complex haplotype for psoriasis in a caucasian population.</article-title><source>J Invest Dermatol</source><volume>124</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">15737195</pub-id></mixed-citation></ref><ref id="pgen.1000606-Balendran1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balendran</surname><given-names>N</given-names></name><name><surname>Clough</surname><given-names>RL</given-names></name><name><surname>Arguello</surname><given-names>JR</given-names></name><name><surname>Barber</surname><given-names>R</given-names></name><name><surname>Veal</surname><given-names>C</given-names></name><etal/></person-group><year>1999</year><article-title>Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3.</article-title><source>J Invest Dermatol</source><volume>113</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">10469328</pub-id></mixed-citation></ref><ref id="pgen.1000606-Nair1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Stuart</surname><given-names>P</given-names></name><name><surname>Henseler</surname><given-names>T</given-names></name><name><surname>Jenisch</surname><given-names>S</given-names></name><name><surname>Chia</surname><given-names>NV</given-names></name><etal/></person-group><year>2000</year><article-title>Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C.</article-title><source>Am J Hum Genet</source><volume>66</volume><fpage>1833</fpage><lpage>1844</lpage><pub-id pub-id-type="pmid">10801386</pub-id></mixed-citation></ref><ref id="pgen.1000606-Nair2"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Stuart</surname><given-names>PE</given-names></name><name><surname>Nistor</surname><given-names>I</given-names></name><name><surname>Hiremagalore</surname><given-names>R</given-names></name><name><surname>Chia</surname><given-names>NV</given-names></name><etal/></person-group><year>2006</year><article-title>Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.</article-title><source>Am J Hum Genet</source><volume>78</volume><fpage>827</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">16642438</pub-id></mixed-citation></ref><ref id="pgen.1000606-Fan1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>ZM</given-names></name><name><surname>Sun</surname><given-names>LD</given-names></name><etal/></person-group><year>2008</year><article-title>Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population.</article-title><source>PLoS Genet</source><volume>4</volume><fpage>e1000038</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000038">10.1371/journal.pgen.1000038</ext-link></comment><pub-id pub-id-type="pmid">18369457</pub-id></mixed-citation></ref><ref id="pgen.1000606-Helms1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helms</surname><given-names>C</given-names></name><name><surname>Saccone</surname><given-names>NL</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Daw</surname><given-names>JA</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><etal/></person-group><year>2005</year><article-title>Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR.</article-title><source>Hum Genet</source><volume>118</volume><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">16235096</pub-id></mixed-citation></ref><ref id="pgen.1000606-Biral1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biral</surname><given-names>AC</given-names></name><name><surname>Magalhaes</surname><given-names>RF</given-names></name><name><surname>Wastowski</surname><given-names>IJ</given-names></name><name><surname>Simoes</surname><given-names>R</given-names></name><name><surname>Donadi</surname><given-names>EA</given-names></name><etal/></person-group><year>2006</year><article-title>Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients.</article-title><source>Eur J Dermatol</source><volume>16</volume><fpage>523</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">17101473</pub-id></mixed-citation></ref><ref id="pgen.1000606-Liao1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>HT</given-names></name><name><surname>Lin</surname><given-names>KC</given-names></name><name><surname>Chang</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Liang</surname><given-names>TH</given-names></name><etal/></person-group><year>2008</year><article-title>Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients.</article-title><source>J Rheumatol</source><volume>35</volume><fpage>891</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">18381784</pub-id></mixed-citation></ref><ref id="pgen.1000606-Rani1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>R</given-names></name><name><surname>Narayan</surname><given-names>R</given-names></name><name><surname>Fernandez-Vina</surname><given-names>MA</given-names></name><name><surname>Stastny</surname><given-names>P</given-names></name></person-group><year>1998</year><article-title>Role of HLA-B and C alleles in development of psoriasis in patients from North India.</article-title><source>Tissue Antigens</source><volume>51</volume><fpage>618</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">9694354</pub-id></mixed-citation></ref><ref id="pgen.1000606-Rahman1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>P</given-names></name><name><surname>Elder</surname><given-names>JT</given-names></name></person-group><year>2005</year><article-title>Genetic epidemiology of psoriasis and psoriatic arthritis.</article-title><source>Ann Rheum Dis</source><volume>64</volume><issue>Suppl 2</issue><fpage>ii37</fpage><lpage>39</lpage><comment>discussion ii40&#x02013;31</comment><pub-id pub-id-type="pmid">15708933</pub-id></mixed-citation></ref><ref id="pgen.1000606-Dorak1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorak</surname><given-names>MT</given-names></name><name><surname>Shao</surname><given-names>W</given-names></name><name><surname>Machulla</surname><given-names>HK</given-names></name><name><surname>Lobashevsky</surname><given-names>ES</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Conserved extended haplotypes of the major histocompatibility complex: further characterization.</article-title><source>Genes Immun</source><volume>7</volume><fpage>450</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">16791278</pub-id></mixed-citation></ref><ref id="pgen.1000606-Jenisch1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenisch</surname><given-names>S</given-names></name><name><surname>Westphal</surname><given-names>E</given-names></name><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Stuart</surname><given-names>P</given-names></name><name><surname>Voorhees</surname><given-names>JJ</given-names></name><etal/></person-group><year>1999</year><article-title>Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes.</article-title><source>Tissue Antigens</source><volume>53</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">10090613</pub-id></mixed-citation></ref><ref id="pgen.1000606-Nedoszytko1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedoszytko</surname><given-names>B</given-names></name><name><surname>Szczerkowska-Dobosz</surname><given-names>A</given-names></name><name><surname>Zablotna</surname><given-names>M</given-names></name><name><surname>Glen</surname><given-names>J</given-names></name><name><surname>Rebala</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population.</article-title><source>Br J Dermatol</source><volume>157</volume><fpage>165</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">17553030</pub-id></mixed-citation></ref><ref id="pgen.1000606-Li1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>TNF-alpha gene promoter -238G&#x0003e;A and -308G&#x0003e;A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis.</article-title><source>J Invest Dermatol</source><volume>127</volume><fpage>1886</fpage><lpage>1892</lpage><pub-id pub-id-type="pmid">17446901</pub-id></mixed-citation></ref><ref id="pgen.1000606-Vasku1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasku</surname><given-names>V</given-names></name><name><surname>Kankova</surname><given-names>K</given-names></name><name><surname>Vasku</surname><given-names>A</given-names></name><name><surname>Muzik</surname><given-names>J</given-names></name><name><surname>Izakovicova Holla</surname><given-names>L</given-names></name><etal/></person-group><year>2002</year><article-title>Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.</article-title><source>Arch Dermatol Res</source><volume>294</volume><fpage>127</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">12029499</pub-id></mixed-citation></ref><ref id="pgen.1000606-Zhang1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhai</surname><given-names>N</given-names></name><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>F</given-names></name></person-group><year>1999</year><article-title>The relationship of HLA-DRB1 &#x0002a; 0701 allele with the psoriasis vulgaris.</article-title><source>Chin Med Sci J</source><volume>14</volume><fpage>70</fpage><pub-id pub-id-type="pmid">12901611</pub-id></mixed-citation></ref><ref id="pgen.1000606-Jee1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jee</surname><given-names>SH</given-names></name><name><surname>Tsai</surname><given-names>TF</given-names></name><name><surname>Tsai</surname><given-names>WL</given-names></name><name><surname>Liaw</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>CH</given-names></name><etal/></person-group><year>1998</year><article-title>HLA-DRB1&#x0002a;0701 and DRB1&#x0002a;1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population.</article-title><source>Br J Dermatol</source><volume>139</volume><fpage>978</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">9990359</pub-id></mixed-citation></ref><ref id="pgen.1000606-Fatma1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatma</surname><given-names>OS</given-names></name><name><surname>Sarper</surname><given-names>DA</given-names></name><name><surname>Dilek</surname><given-names>E</given-names></name><name><surname>Emel</surname><given-names>OA</given-names></name><name><surname>Semra</surname><given-names>A</given-names></name><etal/></person-group><year>2003</year><article-title>HLA-DRB1 association in Turkish psoriasis vulgaris patients.</article-title><source>Swiss Med Wkly</source><volume>133</volume><fpage>541</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">14655055</pub-id></mixed-citation></ref><ref id="pgen.1000606-Zhang2"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>HLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Chinese Han.</article-title><source>Int J Dermatol</source><volume>43</volume><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">15009387</pub-id></mixed-citation></ref><ref id="pgen.1000606-SchmittEgenolf1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt-Egenolf</surname><given-names>M</given-names></name><name><surname>Eiermann</surname><given-names>TH</given-names></name><name><surname>Boehncke</surname><given-names>WH</given-names></name><name><surname>Stander</surname><given-names>M</given-names></name><name><surname>Sterry</surname><given-names>W</given-names></name></person-group><year>1996</year><article-title>Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1&#x0002a;0701-DQA1&#x0002a;0201-DQB1&#x0002a;0303: a population- and family-based study.</article-title><source>J Invest Dermatol</source><volume>106</volume><fpage>711</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">8618009</pub-id></mixed-citation></ref><ref id="pgen.1000606-Gonzalez1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Martinez-Borra</surname><given-names>J</given-names></name><name><surname>Del Rio</surname><given-names>JS</given-names></name><name><surname>Santos-Juanes</surname><given-names>J</given-names></name><name><surname>Lopez-Vazquez</surname><given-names>A</given-names></name><etal/></person-group><year>2000</year><article-title>The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw&#x0002a;0602.</article-title><source>J Invest Dermatol</source><volume>115</volume><fpage>824</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">11069619</pub-id></mixed-citation></ref><ref id="pgen.1000606-Holm1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>SJ</given-names></name><name><surname>Carlen</surname><given-names>LM</given-names></name><name><surname>Mallbris</surname><given-names>L</given-names></name><name><surname>Stahle-Backdahl</surname><given-names>M</given-names></name><name><surname>O'Brien</surname><given-names>KP</given-names></name></person-group><year>2003</year><article-title>Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population.</article-title><source>Exp Dermatol</source><volume>12</volume><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">12930300</pub-id></mixed-citation></ref><ref id="pgen.1000606-Gudjonsson1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudjonsson</surname><given-names>JE</given-names></name><name><surname>Karason</surname><given-names>A</given-names></name><name><surname>Antonsdottir</surname><given-names>A</given-names></name><name><surname>Runarsdottir</surname><given-names>EH</given-names></name><name><surname>Hauksson</surname><given-names>VB</given-names></name><etal/></person-group><year>2003</year><article-title>Psoriasis patients who are homozygous for the HLA-Cw&#x0002a;0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes.</article-title><source>Br J Dermatol</source><volume>148</volume><fpage>233</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">12588373</pub-id></mixed-citation></ref><ref id="pgen.1000606-Nair3"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Duffin</surname><given-names>KC</given-names></name><name><surname>Helms</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Stuart</surname><given-names>PE</given-names></name><etal/></person-group><year>2009</year><article-title>Genome-wide Scan Reveals Association of Psoriasis with IL-23 and NF-kB pathways.</article-title><source>Nat Genet</source><volume>41</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">19169254</pub-id></mixed-citation></ref><ref id="pgen.1000606-deBakker1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Miretti</surname><given-names>MM</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.</article-title><source>Nat Genet</source><volume>38</volume><fpage>1166</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">16998491</pub-id></mixed-citation></ref><ref id="pgen.1000606-Zhang3"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>LD</given-names></name><name><surname>Zhang</surname><given-names>FY</given-names></name><etal/></person-group><year>2009</year><article-title>Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.</article-title><source>Nat Genet</source><volume>41</volume><fpage>205</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">19169255</pub-id></mixed-citation></ref><ref id="pgen.1000606-McMichael1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMichael</surname><given-names>AJ</given-names></name><name><surname>Morhenn</surname><given-names>V</given-names></name><name><surname>Payne</surname><given-names>R</given-names></name><name><surname>Sasazuki</surname><given-names>T</given-names></name><name><surname>Farber</surname><given-names>EM</given-names></name></person-group><year>1978</year><article-title>HLA C and D antigens associated with psoriasis.</article-title><source>Br J Dermatol</source><volume>98</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">147699</pub-id></mixed-citation></ref><ref id="pgen.1000606-Monsuur1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsuur</surname><given-names>AJ</given-names></name><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Verduijn</surname><given-names>W</given-names></name><etal/></person-group><year>2008</year><article-title>Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms.</article-title><source>PLoS ONE</source><volume>3</volume><fpage>e2270</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0002270">10.1371/journal.pone.0002270</ext-link></comment><pub-id pub-id-type="pmid">18509540</pub-id></mixed-citation></ref><ref id="pgen.1000606-Devlin1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Roeder</surname><given-names>K</given-names></name></person-group><year>1999</year><article-title>Genomic control for association studies.</article-title><source>Biometrics</source><volume>55</volume><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">11315092</pub-id></mixed-citation></ref><ref id="pgen.1000606-Miretti1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miretti</surname><given-names>MM</given-names></name><name><surname>Walsh</surname><given-names>EC</given-names></name><name><surname>Ke</surname><given-names>X</given-names></name><name><surname>Delgado</surname><given-names>M</given-names></name><name><surname>Griffiths</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.</article-title><source>Am J Hum Genet</source><volume>76</volume><fpage>634</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">15747258</pub-id></mixed-citation></ref><ref id="pgen.1000606-Banno1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banno</surname><given-names>T</given-names></name><name><surname>Gazel</surname><given-names>A</given-names></name><name><surname>Blumenberg</surname><given-names>M</given-names></name></person-group><year>2005</year><article-title>Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>18973</fpage><lpage>18980</lpage><pub-id pub-id-type="pmid">15722350</pub-id></mixed-citation></ref><ref id="pgen.1000606-Johnston1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>A</given-names></name><name><surname>Gudjonsson</surname><given-names>JE</given-names></name><name><surname>Sigmundsdottir</surname><given-names>H</given-names></name><name><surname>Love</surname><given-names>TJ</given-names></name><name><surname>Valdimarsson</surname><given-names>H</given-names></name></person-group><year>2004</year><article-title>Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(&#x0002b;) T cells.</article-title><source>Clin Exp Immunol</source><volume>138</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15373909</pub-id></mixed-citation></ref><ref id="pgen.1000606-Reischl1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reischl</surname><given-names>J</given-names></name><name><surname>Schwenke</surname><given-names>S</given-names></name><name><surname>Beekman</surname><given-names>JM</given-names></name><name><surname>Mrowietz</surname><given-names>U</given-names></name><name><surname>Sturzebecher</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Increased expression of Wnt5a in psoriatic plaques.</article-title><source>J Invest Dermatol</source><volume>127</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">16858420</pub-id></mixed-citation></ref><ref id="pgen.1000606-Cargill1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cargill</surname><given-names>M</given-names></name><name><surname>Schrodi</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>VE</given-names></name><name><surname>Brandon</surname><given-names>R</given-names></name><etal/></person-group><year>2007</year><article-title>A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.</article-title><source>Am J Hum Genet</source><volume>80</volume><fpage>273</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">17236132</pub-id></mixed-citation></ref><ref id="pgen.1000606-Stephens1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Scheet</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.</article-title><source>Am J Hum Genet</source><volume>76</volume><fpage>449</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">15700229</pub-id></mixed-citation></ref><ref id="pgen.1000606-Stephens2"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>NJ</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><year>2001</year><article-title>A new statistical method for haplotype reconstruction from population data.</article-title><source>Am J Hum Genet</source><volume>68</volume><fpage>978</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">11254454</pub-id></mixed-citation></ref><ref id="pgen.1000606-Mensah1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mensah</surname><given-names>FK</given-names></name><name><surname>Gilthorpe</surname><given-names>MS</given-names></name><name><surname>Davies</surname><given-names>CF</given-names></name><name><surname>Keen</surname><given-names>LJ</given-names></name><name><surname>Adamson</surname><given-names>PJ</given-names></name><etal/></person-group><year>2007</year><article-title>Haplotype uncertainty in association studies.</article-title><source>Genet Epidemiol</source><volume>31</volume><fpage>348</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">17323369</pub-id></mixed-citation></ref><ref id="pgen.1000606-Barrett1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year>2005</year><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation></ref><ref id="pgen.1000606-Purcell1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><etal/></person-group><year>2007</year><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses.</article-title><source>Am J Hum Genet</source><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation></ref><ref id="pgen.1000606-Frazer1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frazer</surname><given-names>KA</given-names></name><name><surname>Ballinger</surname><given-names>DG</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name><name><surname>Hinds</surname><given-names>DA</given-names></name><name><surname>Stuve</surname><given-names>LL</given-names></name><etal/></person-group><year>2007</year><article-title>A second generation human haplotype map of over 3.1 million SNPs.</article-title><source>Nature</source><volume>449</volume><fpage>851</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">17943122</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>ABB and SJS own stock and/or stock options in Celera Corporation.</p></fn><fn fn-type="financial-disclosure"><p>This work was supported by the National Institutes of Health and the Foundation for National Institutes of Health's Genetic Association Information Network. The work in the University of Michigan was supported by awards (R01 AR042742 and R01 AR050511) from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases, National Institutes of Health, by the Ann Arbor VA Hospital, by the Dudley and Dawn Holmes Fund, by the Babcock Memorial Trust, by the National Psoriasis Foundation, and by an award (M01 RR00042) from the National Center for Research Resources, National Institutes of Health. The work in the Anhui Medical University is supported by The Key Project of National Natural Science Foundation of China (30530670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>